AR009333A1 - Procedimiento para preparar formas amorfas de compuestos de 2-fenil-3- benzoil-benzotiofenos y sus sales farmaceuticamente aceptables - Google Patents

Procedimiento para preparar formas amorfas de compuestos de 2-fenil-3- benzoil-benzotiofenos y sus sales farmaceuticamente aceptables

Info

Publication number
AR009333A1
AR009333A1 ARP970103869A ARP970103869A AR009333A1 AR 009333 A1 AR009333 A1 AR 009333A1 AR P970103869 A ARP970103869 A AR P970103869A AR P970103869 A ARP970103869 A AR P970103869A AR 009333 A1 AR009333 A1 AR 009333A1
Authority
AR
Argentina
Prior art keywords
phenyl
pharmaceutically acceptable
benzotiofen
benzoil
compounds
Prior art date
Application number
ARP970103869A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR009333A1 publication Critical patent/AR009333A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Abstract

Se trata de un procedimiento para preparar formas amorfas de compuesto de 2-fenil-3-benzoil-benzotiofenos de formula (I) en la que: R1 y R3 sonindependientemente hidrogeno, -CH3, -CO-(alquilo C1-C6), o -COAr, en el que Ar Es feniloopcionalment e sustituido; R2 se selecciona entre el grupo formadopor pirrolidinilo, hexametilenimino y piperidinilo; o una de sus sales o solvatos farmacéuticamente aceptable; que comprende preparar una solucion deuna forma cristalina de uncompuesto de f ormula (I) en un disolvente adecuado y a continuacion secar por pulverizacion dicha solucion pararecuperar una forma amorfa de un compuesto de formula (I).
ARP970103869A 1996-08-28 1997-08-26 Procedimiento para preparar formas amorfas de compuestos de 2-fenil-3- benzoil-benzotiofenos y sus sales farmaceuticamente aceptables AR009333A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2483196P 1996-08-28 1996-08-28

Publications (1)

Publication Number Publication Date
AR009333A1 true AR009333A1 (es) 2000-04-12

Family

ID=21822611

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP970103869A AR009333A1 (es) 1996-08-28 1997-08-26 Procedimiento para preparar formas amorfas de compuestos de 2-fenil-3- benzoil-benzotiofenos y sus sales farmaceuticamente aceptables
ARP970103870A AR009334A1 (es) 1996-08-28 1997-08-26 Compuestos de 2-fenil-3-benzoil-benzotiofeno solvatos y sales farmaceuticamente aceptables de los mismos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP970103870A AR009334A1 (es) 1996-08-28 1997-08-26 Compuestos de 2-fenil-3-benzoil-benzotiofeno solvatos y sales farmaceuticamente aceptables de los mismos

Country Status (25)

Country Link
EP (1) EP0826682B1 (es)
JP (1) JP2002514174A (es)
KR (1) KR20000035941A (es)
CN (1) CN1244124A (es)
AR (2) AR009333A1 (es)
AT (1) ATE234295T1 (es)
AU (1) AU723987B2 (es)
BR (1) BR9713176A (es)
CA (1) CA2263175A1 (es)
CO (1) CO4650039A1 (es)
CZ (1) CZ64399A3 (es)
DE (1) DE69719640T2 (es)
EA (1) EA002022B1 (es)
ES (1) ES2195089T3 (es)
HU (1) HUP0001172A3 (es)
IL (1) IL128641A (es)
IN (1) IN182940B (es)
NO (1) NO990914L (es)
NZ (1) NZ333839A (es)
PE (1) PE108598A1 (es)
PL (1) PL333356A1 (es)
TR (1) TR199900403T2 (es)
WO (1) WO1998008513A1 (es)
YU (1) YU10599A (es)
ZA (1) ZA977617B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980033284A (ko) * 1996-10-30 1998-07-25 피터지.스트링거 개선된 유방암 예방법
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
FI982733A (fi) 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
EP1832582A1 (en) * 2002-09-30 2007-09-12 A/S GEA Farmaceutisk Fabrik Novel raloxifene malonic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
US20050008704A1 (en) * 2003-07-11 2005-01-13 Ray Anup Kumar Pharmaceutical composition for solubility enhancement of hydrophobic drugs
CA2634056C (en) * 2005-12-21 2014-06-10 Eisai R&D Management Co., Ltd. Amorphous form of 1,2-dihydropyridine compound
GB2456096B (en) 2006-10-17 2011-08-17 Cipla Ltd Crystalline form of benzothiophene compound and process for preparation thereof
ES2437916T3 (es) 2009-07-02 2014-01-15 Synthon B.V. Composición de raloxifeno
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
ITMI20121821A1 (it) * 2012-10-25 2014-04-26 Erregierre Spa Composizione farmaceutica solubile in acqua a base di un sale di raloxifene

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230862A (en) * 1975-10-28 1980-10-28 Eli Lilly And Company Antifertility compounds
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5631369A (en) * 1994-08-31 1997-05-20 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Also Published As

Publication number Publication date
AR009334A1 (es) 2000-04-12
EP0826682A1 (en) 1998-03-04
IL128641A (en) 2001-10-31
HUP0001172A3 (en) 2002-01-28
WO1998008513A1 (en) 1998-03-05
ATE234295T1 (de) 2003-03-15
NO990914D0 (no) 1999-02-25
EA199900235A1 (ru) 1999-08-26
NO990914L (no) 1999-02-25
CO4650039A1 (es) 1998-09-03
KR20000035941A (ko) 2000-06-26
EA002022B1 (ru) 2001-12-24
TR199900403T2 (xx) 2002-01-21
NZ333839A (en) 2001-06-29
ES2195089T3 (es) 2003-12-01
DE69719640T2 (de) 2003-11-06
ZA977617B (en) 1999-02-25
YU10599A (sh) 2001-07-10
HUP0001172A2 (hu) 2001-06-28
IL128641A0 (en) 2000-01-31
DE69719640D1 (de) 2003-04-17
CZ64399A3 (cs) 1999-05-12
BR9713176A (pt) 2000-02-08
PL333356A1 (en) 1999-12-06
AU4233597A (en) 1998-03-19
PE108598A1 (es) 1999-01-13
JP2002514174A (ja) 2002-05-14
EP0826682B1 (en) 2003-03-12
CN1244124A (zh) 2000-02-09
CA2263175A1 (en) 1998-03-05
AU723987B2 (en) 2000-09-07
IN182940B (es) 1999-08-14

Similar Documents

Publication Publication Date Title
AR009333A1 (es) Procedimiento para preparar formas amorfas de compuestos de 2-fenil-3- benzoil-benzotiofenos y sus sales farmaceuticamente aceptables
PE20020179A1 (es) DERIVADOS DE (6S,9R,10S,11S,13S,16R, 17R)-9-CLORO-6-FLUORO-11-HIDROXI-10,13,16-TRIMETIL-3-OXO-6,7,8,9,10,11,12,13,14,15,16,17-DODECAHIDRO-3H-CICLOPENTA[a]FENANTRENO CARBOXILICO
ES2158778B1 (es) Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen.
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
NO20024217D0 (no) 1,5-benzotiazepiner og deres anvendelse som hypolipidmidler
PE2799A1 (es) Lactamas e imidas heterociclicas de aralquilo y aralquilideno
ES2190396T3 (es) Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CO5720995A2 (es) Compuesto novedoso
EA200600348A1 (ru) Новые соединения
NO970349D0 (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT inhibitorer
NO883487L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
AR009413A1 (es) Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende
EA200100994A1 (ru) 1-АМИНОТРИАЗОЛО[4,3-а]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ-IV
NO983493L (no) Nye benzimidazol-, benzoksazol- og benzotiazolforbindelser, fremgangsmÕte ved fremstilling derav og farmas°ytiske sammensetninger inneholdende slike
PE20020524A1 (es) 7-oxo-piridopirimidinas como inhibidores de quinasas
CO4940477A1 (es) Inhibidores de proteasa
AR042362A1 (es) Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen
ATE149164T1 (de) Neue tetrazolderivate, verfahren zu ihrer herstellung und ihre verwendung
FI885083A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara l-prolinderivat.
CO4700300A1 (es) Procedimiento para preparar olanzapina
PT96447A (pt) Processo para a preparacao de um hemi-hidrato de um derivado de tetra-hidroimidazo-piridina
AR036735A1 (es) Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
DK1303514T3 (da) Fremgangsmåde til fremstilling af azacycloalkanoylaminothiazoler
ES2057415T3 (es) Derivados biciclicos.
AR019197A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA ANTIHISTAMINICOS, COMPUESTOS INTERMEDIOS, PROCEDIMIENTO DE PREPARACIoN DE DERIVADOS DE PIPERIDINA Y PROCEDIMIENTOS DE PREPARACIoN DE INTERMEDIARIOS.

Legal Events

Date Code Title Description
FC Refusal